4//SEC Filing
PASSERI DANIEL R 4
Accession 0001209191-21-060022
CIK 0001645460other
Filed
Oct 7, 8:00 PM ET
Accepted
Oct 8, 4:00 PM ET
Size
8.8 KB
Accession
0001209191-21-060022
Insider Transaction Report
Form 4
PASSERI DANIEL R
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Common Stock
2021-09-30+75,000→ 130,377 total - Tax Payment
Common Stock
2021-09-30$14.57/sh−31,677$461,534→ 98,700 total - Exercise/Conversion
Restricted Stock Units
2021-09-30−75,000→ 75,000 total→ Common Stock (75,000 underlying)
Footnotes (3)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
- [F2]Each restricted stock unit award represents a contingent right to receive one share of common stock.
- [F3]One half of the Restricted Stock Units vested on September 30, 2021 and the balance will vest on March 31, 2022.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001190121
Filing Metadata
- Form type
- 4
- Filed
- Oct 7, 8:00 PM ET
- Accepted
- Oct 8, 4:00 PM ET
- Size
- 8.8 KB